Trade ADAG anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Adagene Inc. American Depositary Shares (ADAG) is trading at US$3.76, down 3.72% today as of Aug 28, 13:29 EDT. The company has a market capitalisation of US$265.61M. Over the past 52 weeks, ADAG has traded between US$1.30 and US$4.85. On Syfe you can trade ADAG with $0 commission and add it to your watchlist.
| Previous close | US$3.90 |
|---|---|
| Market cap | US$265.61M |
| 52-week range | US$1.30 – US$4.85 |
| Volume | 296.25K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Adagene Inc. American Depositary Shares
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Year: 2021
Sector Update: Health Care Stocks Decline Premarket Thursday
Apr 2, 1:19 PM · MT Newswires
Adagene, Incyte to Evaluate Muzastotug, INCA33890 in Microsatellite Stable Colorectal Cancer
Apr 2, 11:53 AM · MT Newswires
Adagene Prices $70 Million ADS Public Offering
Apr 2, 11:46 AM · MT Newswires
Stay on top of ADAG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
